MedTrace Logo

A Clinical Trial of Acyclovir for Viral Uveitis

NCT03389191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-04-05

No results posted yet for this study

Summary

This project is designed to test the hypothesis that acyclovir is clinically useful for patients with refractory viral uveitis.

Conditions

  • Uveitis

Interventions

DRUG

Acyclovir

Sponsors & Collaborators

  • Xiaomin Zhang

    lead OTHER

Principal Investigators

  • Xiaomin Zhang, M.D. · Tianjin Medical University Eye Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03389191 on ClinicalTrials.gov